Streamlined Access to AI-Driven Drug Development via a High-Concentration Fund

Deep News

Yesterday

For investors seeking a single-ticket entry into the convergence of artificial intelligence and pharmaceutical innovation, a focused exchange-traded fund offers the most direct pathway.

The Healthcare ETF via Stock Connect (ticker: 159137) stands out as the top-tier choice, featuring the highest concentration of AI-powered drug developers available on the market today.

Specifically, its benchmark index boasts an "AI pharmaceutical content" ratio of 69.5%, the leading figure across all comparable funds. With the MACD indicator flashing a golden cross signal, selected holdings within this portfolio are demonstrating robust upward momentum.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/news/1120685475"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120685475\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120685475?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-18 17:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120685475","market":"sh","top_or_hot":-1,"title":"Streamlined Access to AI-Driven Drug Development via a High-Concentration Fund","media":"Deep News","content":"<p>For investors seeking a single-ticket entry into the convergence of artificial intelligence and pharmaceutical innovation, a focused exchange-traded fund offers the most direct pathway.<br><br>The <b>Healthcare ETF via Stock Connect</b> (ticker: <b>159137</b>) stands out as the top-tier choice, featuring the highest concentration of AI-powered drug developers available on the market today.<br><br>Specifically, its benchmark index boasts an \"AI pharmaceutical content\" ratio of <b>69.5%</b>, the leading figure across all comparable funds. With the MACD indicator flashing a golden cross signal, selected holdings within this portfolio are demonstrating robust upward momentum.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Streamlined Access to AI-Driven Drug Development via a High-Concentration Fund</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStreamlined Access to AI-Driven Drug Development via a High-Concentration Fund\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-09-18 17:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>For investors seeking a single-ticket entry into the convergence of artificial intelligence and pharmaceutical innovation, a focused exchange-traded fund offers the most direct pathway.<br><br>The <b>Healthcare ETF via Stock Connect</b> (ticker: <b>159137</b>) stands out as the top-tier choice, featuring the highest concentration of AI-powered drug developers available on the market today.<br><br>Specifically, its benchmark index boasts an \"AI pharmaceutical content\" ratio of <b>69.5%</b>, the leading figure across all comparable funds. With the MACD indicator flashing a golden cross signal, selected holdings within this portfolio are demonstrating robust upward momentum.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QTOC","symbol_name":"Innovator Growth Accelerated Plus ETF - October","start_time":0,"source_url":"","article_id":"1120685475","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120685475","pubTimestamp":1789725117,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"For investors seeking a single-ticket entry into the convergence of artificial intelligence and pharmaceutical innovation, a focused exchange-traded fund offers the most direct pathway.The Healthcare...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"QTOC":"Innovator Growth Accelerated Plus ETF - October","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","FDN":"First Trust Dow Jones Internet I","01477":"欧康维视生物-B","BK4550":"红杉资本持仓","BK4588":"碎股","BK1191":"制药","ARTY":"ISHARES FUTURE AI & TECH ETF","BK4585":"ETF&股票定投概念","AGIX":"通用人工智能 ETF-AGIX","VTHR":"Vanguard Russell 3000 ETF","BK1574":"生物医药B类股","AIPO":"Defiance AI and Power Infrastructure ETF"},"translate_title":"通过高度集中基金简化人工智能驱动的药物开发","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AIPO":1,"ARTY":1,"FDN":1,"AGIX":1,"QTOC":1,"VTHR":1,"CHAT":1,"01477":1},"content_text":"For investors seeking a single-ticket entry into the convergence of artificial intelligence and pharmaceutical innovation, a focused exchange-traded fund offers the most direct pathway.The Healthcare ETF via Stock Connect (ticker: 159137) stands out as the top-tier choice, featuring the highest concentration of AI-powered drug developers available on the market today.Specifically, its benchmark index boasts an \"AI pharmaceutical content\" ratio of 69.5%, the leading figure across all comparable funds. With the MACD indicator flashing a golden cross signal, selected holdings within this portfolio are demonstrating robust upward momentum.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}